VeriChip to Present at American Medical Directors Association Annual Symposium on March 29-30, 2007
March 29 2007 - 9:30AM
PR Newswire (US)
DELRAY BEACH, Fla., March 29 /PRNewswire-FirstCall/ -- VeriChip
Corporation (NASDAQ:CHIPNASDAQ:-NASDAQ:News), a provider of RFID
systems for healthcare and patient-related needs, will present at
the American Medical Directors Association (AMDA) 30th Annual
Symposium in Hollywood, Florida, on March 29- 30, 2007. The
conference attracts over 4000 medical directors, attending
physicians, nurses, administrators, consultant pharmacists and
other long-term care professionals. VeriChip expects to enroll
additional physicians in its VeriMed Patient Identification System
network through the symposium. Presenting on behalf of VeriChip is
AMDA Foundation Chair and former AMDA President Jonathan Musher,
MD, CMD. AMDA is the professional association of medical directors
and physicians practicing in the long term care continuum dedicated
to excellence in patient care by providing education, advocacy,
information, and professional development. About VeriChip
Corporation VeriChip Corporation, headquartered in Delray Beach,
Florida, develops, markets and sells radio frequency
identification, or RFID, systems used to identify, locate and
protect people and assets. VeriChip's goal is to become the leading
provider of RFID systems for people in the healthcare industry.
VeriChip sells passive RFID systems for identification purposes and
active RFID systems for local-area location and identification
purposes. VeriChip recently began to market its VeriMed(TM) Patient
Identification System for rapidly and accurately identifying people
who arrive in an emergency room and are unable to communicate. This
system uses the first human-implantable passive RFID microchip, the
implantable VeriChip(TM), cleared for medical use in October 2004
by the United States Food and Drug Administration. VeriChip
Corporation is majority-owned by Applied Digital Inc. (NASDAQ:
ADSXNASDAQ:-NASDAQ:News), which also owns a majority position in
Digital Angel Corporation (AMEX:DOCAMEX:-AMEX:News). For more
information on VeriChip, please call 1-800-970- 2447, or email .
Additional information can be found online at
http://www.verichipcorp.com/. Statements about the Company's future
expectations, including future revenues and earnings, and all other
statements in this press release other than historical facts are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and the
Company's actual results could differ materially from expected
results. The Company undertakes no obligation to update
forward-looking statements to reflect subsequently occurring events
or circumstances. Contact: VeriChip Corporation Allison Tomek
561-805-8000 The Ruth Group Nick Laudico (investors) (646) 536-7030
Jason Rando (media) (646) 536-7025 DATASOURCE: VeriChip Corporation
CONTACT: Allison Tomek, VeriChip Corporation, +1-561-805-8000, ; or
Nick Laudico (investors), +1-646-536-7030, , or Jason Rando
(media), +1-646-536-7025, , both of The Ruth Group Web site:
http://www.verichipcorp.com/
Copyright